Key result
IGFBP gene family members are differentially expressed across various cancer types and their expression levels significantly correlate with patient prognosis, tumor mutational burden, and immune microenvironment.
Why the study?
The IGFBP family plays diverse roles across different cancer types, but comprehensive and pleiotropic understandings remain lacking.
Observational
IGFBP expression patterns may refine prognosis in select cancers; leaves open prospective validation before clinical adoption.
BACKGROUND: Insulin-like growth factor binding proteins (IGFBPs) are critical regulators of the biological activities of insulin-like growth factors. The IGFBP family plays diverse roles in different types of cancer, which we still lack comprehensive and pleiotropic understandings so far. METHODS: Multi-source and multi-dimensional data, extracted from The Cancer Genome Atlas (TCGA), Oncomine, Cancer Cell Line Encyclopedia (CCLE), and the Human Protein Atlas (HPA) was used for bioinformatics analysis by R language. Immunohistochemistry and qRT-PCR were performed to validate the results of the database analysis results. Bibliometrics and literature review were used for summarizing the research progress of IGFBPs in the field of tumor. RESULTS: The members of IGFBP gene family are differentially expressed in various cancer types. IGFBPs expression can affect prognosis of different cancers. The expression of IGFBPs expression is associated with multiple signal transduction pathways. The expression of IGFBPs is significantly correlated with tumor mutational burden, microsatellite instability, tumor stemness and tumor immune microenvironment. The qRT-PCR experiments verified the lower expression of IGFBP2 and IGFBP6 in gastric cancer and the lower expression of IGFBP6 in colorectal cancer. Immunohistochemistry validated a marked downregulation of IGFBP2 protein in gastric cancer tissues. The keywords co-occurrence analysis of IGFBP related publications in cancer showed relative research have been more concentrating on the potential of IGFBPs as tumor diagnostic and prognostic markers and developing cancer therapies. CONCLUSIONS: These findings provide frontier trend of IGFBPs related research and new clues for identifying novel therapeutic targets for various cancers.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted an observational in Pan-cancer. IGFBP gene family expression vs. Normal tissue or low expression was evaluated on Differential expression and prognostic value of IGFBPs. IGFBP gene family members are differentially expressed across various cancer types and their expression levels significantly correlate with patient prognosis, tumor mutational burden, and immune microenvironment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: